Contribution of research-based pharmaceutical companies in Germany to personalised medicine

ConclusionsThe literature research clearly shows that although PM is not a new topic and furthermore, the research of pharmaceutical companies in this area is widely required, the number of scientific articles found is very low. The screening of company websites underlines this result as only 19 of 47 companies take a position to PM here and the scope varies greatly. Nevertheless, it is necessary to examine the reasons and how Germany compares to other countries.Key messagesAlthough introduced more than 20 years ago, the appearance of PM by German pharmaceutical companies in scientific articles is quite low.The difference in companies ’ communication should be examined.
Source: The European Journal of Public Health - Category: General Medicine Source Type: research